Evidence map›Paper›PMID 42721147›Full record

ArticlePLOS global public health2026

The public health utility of whole genome sequencing: Insights from a tuberculosis outbreak in Australia and perspectives of public health professionals.

Daisy Wang, Angeline Ferdinand, Justin T Denholm, Katie Dale, Simone Bittmann, Maria Globan, Ben J Marais, Vitali Sintchenko, Christopher Coulter, Martyn D Kirk

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daisy WangNational Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.ORCID https://orcid.org/0009-0003-4969-1383
Angeline FerdinandMicrobiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Justin T DenholmVictorian Tuberculosis Program, The Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital, Melbourne, Australia.ORCID https://orcid.org/0000-0002-9214-6431
Katie DaleVictorian Tuberculosis Program, The Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital, Melbourne, Australia.ORCID https://orcid.org/0000-0002-0655-1685
Simone BittmannVictorian Tuberculosis Program, The Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital, Melbourne, Australia.
Maria GlobanVictorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection & Immunity, Melbourne Health, Melbourne, Australia.ORCID https://orcid.org/0000-0002-3400-2843
Ben J MaraisSydney Infectious Diseases Institute, University of Sydney, Sydney, Australia.
Vitali SintchenkoSydney Infectious Diseases Institute, University of Sydney, Sydney, Australia.
Christopher CoulterCommunicable Diseases Branch, Department of Health, Brisbane, Australia.
Martyn D KirkNational Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia.ORCID https://orcid.org/0000-0001-5432-5984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole Genome Sequencing (WGS) is increasingly being used to enhance tuberculosis (TB) surveillance and management. However, evidence on how WGS shapes real-world decision-making remains limited. This study explored the utility of WGS in the context of a TB outbreak in Victoria, Australia. We conducted a case study to (1) describe a TB outbreak in Victoria using epidemiological and genomic data and (2) explore the perceived benefits and limitations of WGS through qualitative interviews with laboratory and public health professionals involved in the investigation. The interviews were analysed thematically. From 2017 - 2023, 36 people were linked to a large lineage 4 TB outbreak comprising 3 sub-clusters. WGS connected two patients who were initially not epidemiologically linked to the outbreak, prompting additional contact screening at a medical clinic. From interviews with 10 laboratory and public health professionals, WGS was considered a useful tool, although there was a gap between its potential and realised utility. WGS strengthened confidence in suspected transmission links, which was particularly valuable when epidemiological evidence was sparce or uncertain. This was relevant in this investigation where TB stigma, a prolonged timeframe, and cross-jurisdictional transmission were challenges. Barriers to public health action from WGS included long turnaround times, difficulties drawing conclusions from identical isolates, and uncertainties around public health follow-up actions. This case study demonstrates that WGS can inform meaningful public health action, while also identifying opportunities to improve its utility. WGS for public health should involve real-time sequencing along with steps to support the translation of findings into actions such as action-focused WGS training, mechanisms to support consistent follow-up, and improved record-keeping systems.

Identifiers

PMID42721147
PMCPMC13561327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.